Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
about
The benefits and risks of testosterone replacement therapy: a reviewTestosterone deficiency in the aging maleTestosterone Replacement Therapy and Prostate Cancer IncidenceChallenges to treat hypogonadism in prostate cancer patients: implications for endocrinologists, urologists and radiotherapistsTestosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic riskCurrent opinion on the role of testosterone in the development of prostate cancer: a dynamic modelThe treatment of late-onset hypogonadismThe Regulation of Steroid Action by Sulfation and DesulfationDiabetes and cancer: two diseases with obesity as a common risk factorA perspective on the role of estrogen in hormone-induced prostate carcinogenesisAndrogens and prostate diseaseAndropause: Current conceptsMale pattern baldness in relation to prostate cancer risks: an analysis in the VITamins and lifestyle (VITAL) cohort study.Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practicesCoumaphos exposure and incident cancer among male participants in the Agricultural Health Study (AHS)Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapyTestosterone deficiency: a historical perspective.Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer.A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer RiskSelenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.Pooling biomarker data from different studies of disease risk, with a focus on endogenous hormones.Testosterone treatment is a potent tumor promoter for the rat prostate.Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancerCYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging.Androgens, growth factors, and risk of prostate cancer: the Multiethnic CohortOff-label use of hormones as an antiaging strategy: a reviewTestosterone deficiency and replacement: Myths and realities.A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumThe transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reductionSex hormones and the risk of incident prostate cancerEmerging medication for the treatment of male hypogonadism.Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.Alcoholic beverages and prostate cancer in a prospective US cohort studyIs there a role for body mass index in the assessment of prostate cancer risk on biopsy?Prevention and early detection of prostate cancer.Single-nucleotide polymorphism, rs1799941 in the Sex Hormone-Binding Globulin (SHBG) gene, related to both serum testosterone and SHBG levels and the risk of myocardial infarction, type 2 diabetes, cancer and mortality in men: the Tromsø Study.
P2860
Q24658011-57D093C7-11D0-4261-89F0-D89802A9EEC8Q26770414-5357EA1C-89ED-4225-9FB2-3CDEE1757630Q26771774-316B8DFF-C172-4E93-833D-157FBD038FFBQ26773738-CF5E9F3B-890C-4CF1-9FB4-24464BE9EBC5Q26775766-CA365635-8E6C-4809-9B08-993A3F566C02Q26778886-C34D2E1C-EACF-4057-A38C-B8C1A26AFC57Q26795519-604BBE6C-E123-4C88-ABBD-FDC5F986CFE3Q26799364-74C2EB4F-EF55-4BD6-BE08-024E95B13FD4Q26822753-2DE1E535-B41F-40E7-B9E2-98F51B4BF9BDQ27004552-1C69050C-3DDF-4064-ACD0-C2AB9AE3B511Q27010093-60DFF62E-DD2C-4D4C-BCE2-1FE1263DC0FDQ27024886-E3672503-CDA3-4D62-9AB5-A7F966E2847AQ27331357-8371C03B-75DE-4740-B287-DF6937DCF769Q28068397-AE19EC81-12B8-4F43-9E82-0E3AD81CBD00Q28295533-FFE06A16-2BE3-4AB5-8D19-FEF604B77867Q28394004-ABF58800-9EB4-41F9-9973-6D208B89561CQ28829239-057317D0-BCB1-4EE2-AA05-42F0BDAC9E8CQ30441292-3E6D0CDD-1462-4852-AF91-DF625F911D78Q30497028-C3683494-4FF7-4D62-9EE5-7114A2A0B475Q30565173-B6A0179C-4CFC-4767-A660-C6CBFEA85F0CQ31049602-FE4D41D1-77E9-4EBB-99FA-0F090755B071Q31112967-617CC42D-B4F0-4CC8-ADF4-5AD0FA8D3EBEQ33374241-6AB32833-0D4E-4C6B-9192-069A8D89D61EQ33541391-B0DD4E16-3F6A-4FEF-A3E5-AABBD1BC3D81Q33569704-2FDB8917-64C6-4890-A947-3CAED76547FBQ33599365-84B08621-2EFD-415D-95E9-8F64F53C1C75Q33616702-F01177A2-2935-4E18-9D6A-07E4309680A1Q33764496-01C42886-C5F5-4D04-9C9B-241ECAFBFB85Q33814527-01B3ECF9-0B24-4963-86DE-27FCC4E5D90DQ33976165-05D14BD0-F18B-4681-A36C-7AF63B9E44D4Q34093530-E8A8045C-DB17-4C27-A50E-961D37C4FFB9Q34113217-C677DAB3-61A7-4DCF-91BA-D663249D44B4Q34127128-ECE37830-4817-44B5-82FF-FA67FAA14FC3Q34274282-8DDDE8AA-6C51-4CEC-848B-D94574200C9AQ34276286-C386D8D3-4E42-4B14-BDDE-EB84C72145E2Q34299696-CD679662-3F5C-44E7-B000-194006971B1BQ34320865-84AC2788-6344-4B66-B26B-BBA75D987A91Q34325137-A15B37DB-8178-4E45-9752-08AC55E142B3Q34371057-6274929A-7492-4E95-BE52-50DB085066D6Q34391105-324CE532-313D-473D-9577-A9426D46D8D1
P2860
Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Endogenous sex hormones and pr ...... sis of 18 prospective studies.
@en
Endogenous sex hormones and pr ...... sis of 18 prospective studies.
@nl
type
label
Endogenous sex hormones and pr ...... sis of 18 prospective studies.
@en
Endogenous sex hormones and pr ...... sis of 18 prospective studies.
@nl
prefLabel
Endogenous sex hormones and pr ...... sis of 18 prospective studies.
@en
Endogenous sex hormones and pr ...... sis of 18 prospective studies.
@nl
P2093
P2860
P356
P1476
Endogenous sex hormones and pr ...... sis of 18 prospective studies.
@en
P2093
Andrew W Roddam
Endogenous Hormones and Prostate Cancer Collaborative Group
Naomi E Allen
Paul Appleby
Timothy J Key
P2860
P304
P356
10.1093/JNCI/DJM323
P407
P577
2008-01-29T00:00:00Z